Delaware
(State
or other jurisdiction of
incorporation
or organization)
|
6770
(Primary
Standard Industrial
Classification
Code Number)
3
Manhattanville Road
Purchase,
New York 10577
(914)
272-8067
|
26-0500600
(I.R.S.
Employer
Identification
Number)
|
Samir
A. Gandhi, Esq.
|
Floyd
I. Wittlin, Esq.
|
Sidley
Austin LLP
|
Bingham
McCutchen LLP
|
787
Seventh Avenue
|
399
Park Avenue
|
New
York, New York 10019
|
New
York, New York 10022
|
(212)
839-5300
|
(212)
705-7000
|
(212)
839-5599—Facsimile
|
(212)
702-3625—Facsimile
|
________________________________
|
CALCULATION
OF REGISTRATION FEE
|
||||
Title
of Each Class of
Security
to be Registered
|
Amount
being Registered
|
Proposed
Maximum
Offering Price per Security(1)
|
Proposed
Maximum
Aggregate Offering Price(1)
|
Amount
of Registration Fee
|
Units,
each consisting of one share of Common
Stock,
$.0001 par value, and one Warrant(2)
|
34,500,000
Units
|
$10.00
|
$345,000,000
|
$10,592
|
Shares
of Common stock included as part of the Units
|
34,500,000
Shares
|
---
|
---
|
---
(3)
|
Warrants
included as part of the Units
|
34,500,000
Warrants
|
---
|
---
|
---
(3)
|
Shares
of Common Stock underlying the Warrants included in the Units(4)
|
34,500,000
Shares
|
$7.50
|
$258,750,000
|
$7,944
|
Total
|
$603,750,000
|
$18,536(5)
|
(1)
|
Estimated
solely for the purpose of calculating the registration
fee.
|
(2)
|
Includes
4,500,000 Units and 4,500,000 shares of Common Stock and 4,500,000
Warrants underlying such Units which may be issued on exercise of
a 30-day
option granted to the Underwriters to cover over-allotments, if
any.
|
(3)
|
No
fee required pursuant to Rule
457(g).
|
(4)
|
Pursuant
to Rule 416, there are also being registered such additional securities
as
may be issued to prevent dilution resulting from stock splits, stock
dividends or similar transactions as a result of the anti-dilution
provisions contained in the
Warrants.
|
(5)
|
Previously
paid.
|
Per
Unit
|
Total(1)
|
|
Public
Offering Price
|
$ 10.00
|
$300,000,000
|
Underwriting
Discounts and Commissions(2)(3)
|
$ 0.70
|
$21,000,000
|
Proceeds,
Before Expenses, to Us
|
$ 9.30
|
$279,000,000
|
|
(1)
|
The
underwriters have an option to purchase up to an additional 4,500,000
units at the public offering price, less underwriting discounts and
commissions, within 30 days of the date of this prospectus to cover
any
over-allotments. If the underwriters exercise this option in
full, the total public offering price, underwriting discounts and
commissions and proceeds, before expenses, to us, will be $345,000,000,
$24,150,000 and $320,850,000, respectively. See the section
entitled “Underwriting” on page 105 of this
prospectus.
|
|
(2)
|
Includes
deferred underwriting discounts and commissions equal to 3.5% of
the gross
proceeds, or $10,500,000 ($12,075,000 if the underwriters’ over-allotment
option is exercised in full), or $0.35 per unit, which will be deposited
in a trust account at JPMorgan Chase Bank, N.A., maintained by Continental
Stock Transfer & Trust Company, as trustee, and which the underwriters
have agreed to defer until the consummation of our initial business
combination. However, the underwriters have waived their right
to the deferred discounts and commissions with respect to those units
as
to which the component shares have been converted into cash by public
stockholders who voted against the business combination and exercised
their conversion rights. See “Underwriting—Discounts and
Commissions.”
|
|
(3)
|
Of
the net proceeds we receive from this offering and in the private
placement, including deferred underwriting discounts and commissions
of
$10,500,000 ($12,075,000, if the underwriters’ over-allotment option is
exercised in full), or $0.35 per unit, $296,450,589 ($339,875,589
if the
underwriters’ over-allotment option is exercised in full), or
approximately $9.88 per unit, will be deposited in a trust account
at
JPMorgan Chase Bank, N.A., maintained by Continental Stock Transfer
&
Trust Company, as trustee. The underwriters are not receiving
any discounts or commissions with respect to the warrants to be purchased
in the private placement.
|
PROSPECTUS
SUMMARY
|
1
|
RISK
FACTORS
|
20
|
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
44
|
USE
OF PROCEEDS
|
45
|
CAPITALIZATION
|
50
|
DILUTION
|
51
|
DIVIDEND
POLICY
|
53
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
54
|
PROPOSED
BUSINESS
|
57
|
MANAGEMENT
|
80
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
|
85
|
PRINCIPAL
STOCKHOLDERS
|
89
|
DESCRIPTION
OF SECURITIES
|
91
|
UNITED
STATES FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS
|
99
|
UNDERWRITING
|
105
|
LEGAL
MATTERS
|
111
|
EXPERTS
|
111
|
WHERE
YOU CAN FIND ADDITIONAL INFORMATION
|
111
|
•
|
references
to “we,” “us,” or “our” refer to NRDC Acquisition
Corp.;
|
•
|
the
term “business combination” as used in this prospectus means an
acquisition by us through a merger, capital stock exchange, stock
purchase, asset acquisition, or other similar business combination
with one or more operating
businesses;
|
•
|
the
term “existing stockholders” refers to those persons who owned shares of
our common stock immediately prior to the completion of this offering
and
includes all of our executive officers and
directors;
|
•
|
the
term “sponsor” refers to NRDC Capital Management, LLC, one of our existing
stockholders;
|
•
|
the
term “public stockholder” refers to those persons who purchase securities
offered by this prospectus in this offering or in the secondary market,
including any of our existing stockholders;
and
|
•
|
the
information in this prospectus reflects a 6 for 5 stock split of
our
common stock to be effected prior to this
offering.
|
•
|
An
Established Business with a Proven Operating Track
Record. We will seek established businesses with records
of strong financial performance and sound operating results, or ones
which
our management team believes have the potential for positive operating
cash flow. It is not our intention to acquire a start-up
company.
|
•
|
Strong
Industry Position. We will seek to acquire strong
competitors in industries with appealing prospects for future growth
and
profitability. We will examine the ability of these target businesses
to
defend and improve their advantages in areas such as customer base,
branding, intellectual property, vendor relationships, working capital
and
capital investments.
|
•
|
Experienced
Management Team. We will concentrate on target businesses
with an experienced management team that has created an effective
corporate culture and utilized best business practices in areas such
as
customer service, vendor relationships, recruiting and
retention.
|
•
|
Ability
For Us To Add Value. We will seek a target company where
our management team has identified opportunities to improve the operating
business through the implementation of marketing, operational, growth
and
management strategies to augment the company’s existing
capabilities.
|
•
|
Underlying
Real Estate Value. Given the inherent skills and
experience of our management team, we will focus initially on operating
businesses where we have the opportunity to create value from the
real
estate underlying the business.
|
Securities
Offered:
|
30,000,000
units, at $10.00 per unit, each unit consisting of:
|
|
•
one
share of common stock; and
|
|
•
one warrant.
|
|
The units will begin trading on or promptly after the date of this prospectus. |
Trading
Commencement and
|
|
Separation
of Common Stock
|
|
and
Warrants:
|
The
common stock and warrants will begin trading separately five
trading days
after the earlier to occur of the termination of the underwriters’ option
to purchase up to 4,500,000 additional units to cover over-allotments
and
the exercise in full of that option. In no event will separate
trading of the common stock and warrants commence until we
have filed an
audited balance sheet reflecting our receipt of the proceeds
of this
offering and issued a press release announcing when separate
trading will
begin. We will file a Current Report on Form 8-K, including an
audited balance sheet, promptly after the completion of this
offering. The audited balance sheet will include proceeds we
receive from the exercise of the over-allotment option if the
over-allotment option is exercised prior to the filing of the
Current
Report on Form 8-K and, if such over-allotment option is exercised
after
such time, we will file an additional Current Report on Form
8-K including
a balance sheet reflecting our receipt of the proceeds from
the exercise
of the over-allotment. For more information, see the section in
this prospectus entitled “Description of
Securities—Units.”
|
Common
Stock:
|
|
Number
of shares outstanding
|
|
before
the date of this prospectus:
|
7,500,000
shares (does not include 1,125,000 shares sold to our sponsor
that are
subject to forfeiture to the extent the underwriters do not
exercise their
over-allotment option but gives effect to a 6 for 5 stock split
of our
common stock effected on September 4, 2007)
|
Number
of shares to be outstanding
|
|
after
completion of this offering:
|
37,500,000
shares (does not include 1,125,000 shares sold to our sponsor
that are
subject to forfeiture to the extent the underwriters do not
exercise their
over-allotment option but gives effect to a 6 for 5 stock split
of our
common stock effected on September 4, 2007)
|
Warrants:
|
|
Number
of warrants outstanding before
|
|
the
date of this prospectus:
|
0
warrants
|
Number
of warrants to be outstanding
|
|
after
completion of this offering and
|
|
the
private placement:
|
38,000,000
warrants
|
Exercisability:
|
Each
warrant is exercisable for one share of common stock.
|
Exercise
price:
|
$7.50
|
Exercise
period:
|
The
warrants will become exercisable on the later of the consummation
of our
initial business combination and _______, 2008 on the terms described
in
this prospectus; provided that a registration statement covering
the
shares of common stock issuable upon exercise of the warrants
is effective
and a current prospectus is available for use.
|
|
The
warrants will expire at 5:00 p.m., New York City time, on __________,
2011
or earlier upon redemption of the warrants by
us.
|
Redemption:
|
We
may redeem the outstanding warrants (excluding the warrants
included in
the co-investment units) at any time after the warrants become
exercisable:
|
•
in whole and not in part;
|
|
•
at a price of $0.01 per warrant;
|
|
•
upon a minimum of 30 days’ prior written notice; and
|
|
•
only if the last sales price of our common stock on the American
Stock
Exchange, or other national securities exchange on which our
common stock
may be traded, equals or exceeds $14.25 per share for any 20
trading days
within a 30-trading-day period ending three business days before
we send
the notice of redemption, a registration statement under the
Securities
Act relating to the shares of common stock issuable upon exercise
of the
warrants is effective and expected to remain effective to and
including
the redemption date, and a prospectus relating to the shares
of common
stock issuable upon exercise of the warrants is available for
use by the
public warrant holders and remains available for use to and including
the
redemption date.
|
|
We
established the last criterion to provide warrant holders with
a premium
to the initial warrant exercise price, as well as a degree of
liquidity to
cushion the market reaction, if any, to our election to redeem
the
warrants. If the above conditions are satisfied and we call the
warrants for redemption, the warrant holders will then be entitled
to
exercise their warrants before the date scheduled for
redemption. However, there can be no assurance that the price
of the common stock will exceed $14.25 or the warrant exercise
price after
the redemption call is made. We do not need the consent
of
|
the
underwriters or our stockholders to redeem the outstanding
warrants.
|
|
Initial
shares:
|
In
July 2007, our sponsor purchased 8,625,000 shares of our common
stock
(after giving effect to a 6 for 5 stock split of our common
stock effected
on September 4, 2007) for an aggregate purchase price of
$25,000. The initial shares are identical to the shares
included in the units being sold in this offering, except
that:
|
•
the initial shares are subject to transfer
restrictions;
|
|
•
our existing stockholders have agreed to vote the initial shares
in the
same manner as a majority of the public stockholders in connection
with
the vote required to approve our initial business
combination;
|
|
•
our existing stockholders will not be able to exercise conversion
rights
(as described below) with respect to their initial shares;
and
|
|
•
our existing stockholders have agreed to waive their rights
to participate
in any liquidation distribution with respect to their initial
shares if we
fail to consummate a business combination.
|
|
Of
the 8,625,000 shares of common stock originally purchased by
our sponsor,
1,125,000 shares will be forfeited to us to the extent the
underwriters do
not exercise their over-allotment option. After giving effect
to such forfeiture and assuming no purchase of units by our
existing
shareholders in this offering, the number of shares of common
stock owned
by our existing stockholders will be 20% of the total number
of shares of
common stock outstanding after completion of this
offering.
|
|
Private
placement:
|
Our
sponsor has agreed to purchase an aggregate of 8,000,000 warrants
from us
at a price of $1.00 per warrant, for an aggregate purchase
price of
$8,000,000, in a private placement immediately prior to the
completion of
this offering. With certain exceptions, the private placement
warrants may not be sold or transferred until after we have
consummated
our initial business combination. The private placement
warrants will be identical to the warrants underlying the units
offered by
this prospectus except that the private placement warrants
are exercisable
on a cashless basis so long as they are held by our sponsor
or its
permitted transferees.
|
Our
sponsor and its permitted transferees will have the right to
exercise the
private placement warrants on a cashless basis, after delivery
of a notice
of redemption by us. Warrants included in the units issued in
this offering are not exercisable on a cashless
basis.
|
Our
sponsor will be permitted to transfer its private placement
warrants to
its members, former members, members of their immediate families
or controlled affiliates of our sponsor, which we refer to as
“permitted transferees.” Our sponsor and its permitted
transferees may make transfers of these private placement warrants
to
charitable organizations and trusts for estate planning purposes,
to our
other officers and directors, pursuant to a qualified domestic
relations
order and in the event of a merger, capital stock exchange,
stock
purchase, asset acquisition or other similar transaction which
results in
all of our stockholders having the right to exchange their
shares of
common stock or other securities for cash, securities or other
property
subsequent to our consummation of our initial business
combination.
|
|
Co-Investment
units purchased
|
|
through
private placement:
|
Our
sponsor has agreed to purchase from us an aggregate of 2,000,000
of our
units at a price of $10.00 per unit for an aggregate purchase
price of $20,000,000 in a private placement that will occur
immediately
prior to the consummation of our initial business
combination. Our initial business combination will not occur
until after the signing of a definitive business combination
agreement and
the approval of that business combination by our stockholders,
provided
that holders of less than 30% of the shares of common stock
sold in this
offering both vote against our initial business combination
and exercise
their conversion rights as described in this prospectus, and
a majority of
the outstanding shares of our common stock are voted in favor
of an
amendment to our amended and restated certificate of incorporation
to
provide for our perpetual existence. Each unit will consist of
one share of common stock and one warrant. We refer to this
private placement as the co-investment and these private placement
units,
shares of common stock and warrants as the co-investment units,
co-investment common stock and co-investment warrants, respectively,
throughout this
prospectus.
|
The co-investment units will be identical to the units sold in this offering except that the common stock and the warrants included in the co-investment units, and the common stock issuable upon exercise of those warrants, with certain limited exceptions, may not be transferred or sold for one year after the consummation of our initial business combination. Additionally, the warrants included in the co-investment units are (1) exercisable only after the date on which the last sales price of our common stock on the American Stock Exchange, or other national securities exchange on which our common stock may be traded, equals or exceeds $14.25 per share for any 20 trading days within any 30-trading-day period beginning at least 90 calendar days after the consummation of our initial business combination, (2) exercisable on a cashless basis so long as they are held by the original purchaser or its permitted transferees and (3) not subject to redemption by us. | |
Upon consummation of the co-investment, our sponsor would own approximately 24.1% of our outstanding common stock, assuming |
that no additional shares are otherwise issued as consideration for our initial business combination and that our sponsor does not purchase any additional shares of our common stock in this offering or in the secondary market. Pursuant to the registration rights agreement, the holder of our co-investment units and the common stock and the warrants included therein will be entitled to certain registration rights one year after the consummation of our initial business combination, or such later time as when such securities become transferable or exercisable. | |
As the proceeds from the sale of the co-investment units will not be received by us until immediately prior to our consummation of a business combination, these proceeds will not be deposited into the trust account and will not be available for distribution to our public stockholders in the event of a liquidating distribution. Our sponsor will not receive any additional carried interest (in the form of additional units, common stock, warrants or otherwise) in connection with the co-investment. | |
Our sponsor has agreed, subject to certain exceptions described below, not to transfer, assign or sell any of its co-investment units, the co-investment common stock or co-investment warrants (including the common stock to be issued upon exercise of the co-investment warrants) until one year after we consummate a business combination. | |
Our sponsor will be permitted to transfer its co-investment units, the co-investment common stock or co-investment warrants (including the common stock to be issued upon exercise of the co-investment warrants) to its permitted transferees. Our sponsor and its permitted transferees may make transfers of these securities to charitable organizations and trusts for estate planning purposes, to our other officers and directors, pursuant to a qualified domestic relations order and in the event of a merger, capital stock exchange, stock purchase, asset acquisition or other similar transaction which results in all of our stockholders having the right to exchange their shares of common stock or other securities for cash, securities or other property subsequent to our consummation of our initial business combination. | |
The business purpose of the co-investment is to provide additional capital to us and to demonstrate our sponsor’s further commitment to our completion of a business combination. In the event that the co-investment units are not purchased immediately prior to our consummation of our initial business combination, each person that has a co-investment obligation has agreed to forfeit all of the shares and private placement warrants that such person purchased from us prior to the completion of this offering. | |
Proposed
American Stock Exchange symbols for our securities:
|
|
Units:
|
NAQ.U
|
Common
Stock:
|
NAQ
|
Warrants:
|
NAQ.WS
|
Offering
proceeds to be held in
|
the
trust account:
|
$296,450,589
of the proceeds from this offering and the private placement
(approximately $9.88 per unit) will be deposited in a trust account
at
JPMorgan Chase Bank, N.A., maintained by Continental Stock Transfer
&
Trust Company, as trustee, pursuant to an agreement to be signed
prior to
the date of this prospectus. Of the proceeds held in the trust
account, $10,500,000, representing deferred underwriting discounts
and
commissions, will be paid to the underwriters upon consummation
of our
initial business combination (subject to a $0.35 per share reduction
for
public stockholders who vote against the initial business combination
and
exercise their conversion rights as described below). The
proceeds held in the trust account will not be released until
the earlier
of (x) the consummation of our initial business combination on
the terms
described in this prospectus or (y) our liquidation. There can
be released to us from the trust account (i) interest income
earned on the
trust account balance to pay any income taxes on such interest
and (ii)
interest income earned, after taxes payable, on the trust account
of up to
an aggregate amount of $2,250,000 to fund our working capital
requirements, including, in such an event, the costs of our
liquidation. See “Use of Proceeds.” All remaining
interest earned on the trust account (after taxes payable) will
remain in
the trust account for our use in consummating an initial business
combination and for payment of the deferred underwriting compensation
or
released to the public stockholders upon their exercise of conversion
rights or upon our liquidation. Unless and until
an initial business combination is consummated, the proceeds
held in the
trust account will not be available for our use for any expenses
related
to this offering or any expenses which we may incur related to
the
investigation and selection of a target business or the negotiation
of an
agreement to consummate an initial business combination, including
to make
a down payment or deposit or fund a lock-up or “no-shop” provision with
respect to a potential business combination. These expenses may
be paid prior to an initial business combination only from the
$250,000 of
net proceeds from this offering not held in the trust account
plus
interest earned on the trust account of up to $2,250,000, after
tax, as
set forth above.
|
Although we do not know the exact rate of interest to be earned on the trust account, we believe that the recent historical interest rates of U.S. Treasury Bills with less than six months maturities are indicative of the interest to be earned on the funds in the trust account. According to the Federal Reserve Statistical Release dated September 24, 2007, referencing historical interest rate data which appears on the Federal Reserve website, U.S. Treasury Bills with four week, three month and six month maturities were yielding, as of the week ended September 21, 2007, 3.52%, 3.82% and 3.99% per annum, respectively. However, the actual interest rates that we |
receive on the funds in the trust account may be different than these rates. |
None of the warrants may be exercised until after the consummation of our initial business combination. Thus, after the proceeds of the trust account have been disbursed, upon the exercise of any warrants, the warrant exercise price will be paid directly to us. |
Payments to executive officers and |
directors and existing stockholders: | There will be no compensation, fees or other payments paid to our executive officers, directors and existing stockholders or any of their respective affiliates prior to, or for any services they render in order to effectuate, the consummation of our initial business combination other than: |
|
•
|
repayment
of a $200,000 interest-free loan made by our sponsor to cover expenses
relating to the offering contemplated by this
prospectus;
|
|
•
|
payment
to our sponsor or its assignee of a monthly fee of $7,500 for general
and
administrative services, including office space, utilities, and
secretarial support. We believe that, based on rents and fees
for similar services in Purchase, New York, the fees charged by
our
sponsor are at least as favorable as we could have obtained from
unaffiliated third parties; and
|
|
•
|
reimbursement
of out-of-pocket expenses incurred by our executive officers and
directors
in connection with activities on our behalf, such as identifying
and
investigating target businesses for our initial business
combination.
|
Right
of first offer:
|
We
have entered into a business opportunity right of first offer
agreement
with our sponsor, NRDC Real Estate Advisors, LLC and NRDC Equity
Partners
and with our executive officers and directors. This right of
first offer provides that, subject to the respective pre-existing
fiduciary duties of our executive officers and directors, from
the date of
this prospectus until the earlier of the consummation of our
initial
business combination or our liquidation, we will have a right
of first
offer if any of these parties becomes aware of, or involved with,
a
business combination opportunity with any operating
business. Subject to the respective pre-existing fiduciary
duties of our executive officers and directors, these parties
to the right
of first offer agreement will, and will cause companies or entities
under
their management or control, to first offer any such business
opportunity
to us and they will not, and will cause each other company or
entity under
their management or control not, to pursue any such business
opportunity
unless and until our board of directors, including a majority
of our
disinterested independent directors, has determined that we will
not
pursue such opportunity.
|
|
We
recognize that each of our executive officers and directors may
be deemed
an affiliate of any company for which such executive officer or
director
serves as an officer or director or for which such executive officer
or
director otherwise has a pre-existing fiduciary duty and that a
conflict
of interest could arise if an opportunity is appropriate for one
of such
companies. As part of this right of first offer, we have
established procedures with respect to the sourcing of a potential
business combination by our executive officers and directors to
eliminate
such conflict for our executive officers and directors, whereby
a
potential business combination that must be presented to any company
for
which such executive officer or director, as the case may be, serves
as an
officer or director or otherwise has a pre-existing fiduciary duty
(other
than our sponsor, NRDC Real Estate Advisors, LLC and NRDC Equity
Partners)
will not be presented to us until after such executive officer
or director
has presented the opportunity to such company and such company
has
determined not to proceed.
|
The stockholders must approve |
our
initial business combination:
|
We
will seek stockholder approval before we consummate our initial
business
combination, even if the nature of the acquisition would
not ordinarily
require stockholder approval under applicable state law. In
connection with any vote required for our initial business
combination,
our executive officers, directors and existing stockholders
have agreed to
vote all of the shares of common stock owned by them prior
to the
completion of this offering with respect to our initial business
combination in the same manner that the majority of the shares
of common
stock offered hereby are voted by our public stockholders
other than our
existing stockholders. Our executive officers, directors and
existing stockholders also have agreed that if they acquire
shares of
common stock in or following completion of this offering,
they will vote
all such acquired shares in favor of our initial business
combination. We will proceed with our proposed initial business
combination only
if:
|
|
•
|
a
majority of the shares of common stock voted by the public stockholders
are voted in favor of the initial business
combination;
|
|
•
|
public
stockholders owning less than 30% of the shares sold in this offering
both
vote against our initial business combination and exercise their
conversion rights as described below;
and
|
|
•
|
a
majority of our outstanding shares of common stock are voted in
favor of
an amendment to our amended and restated certificate of incorporation
to
provide for our perpetual existence, as described
below.
|
|
Voting
against the initial business combination alone will not result
in an
election to exercise a stockholder’s conversion rights. A
stockholder must also affirmatively exercise such conversion
rights at or
prior to the time an initial business combination is voted
upon
|
by the stockholders. We view the procedures governing the approval of our initial business combination, each of which are set forth in our amended and restated certificate of incorporation, as obligations to our stockholders, and neither we nor our board of directors will propose, or seek stockholder approval of, any amendment of these procedures. For more information, see the section entitled “Proposed Business—Consummating an Initial Business Combination—Stockholder Approval of Our Initial Business Combination.” |
Conversion
rights for stockholders
voting
to reject our initial business
|
combination:
|
Public
stockholders voting against our initial business combination will
be
entitled to convert their stock into a pro rata share of the
aggregate amount then in the trust account (including the amount
held in
the trust account representing the deferred portion of the underwriting
discounts and commissions), including any interest earned on their
pro
rata share (net of taxes payable on such interest income and after
release of an aggregate amount up to $2,250,000 of interest income,
after
tax, to fund working capital requirements), if the initial business
combination is approved and consummated. Public stockholders
who convert their stock into a pro rata share of the trust
account will continue to have the right to exercise any warrants
they may
hold. Our existing stockholders will not have any conversion
rights with respect to shares of common stock held by them prior
to the
completion of this offering or with respect to any of the shares
sold in
this offering that they may acquire and there will be no conversion
rights
with respect to the 2,000,000 shares of common stock included in
the
co-investment units.
|
This conversion could have the effect of reducing the amount distributed to us from the trust account by up to approximately $85,785,167 (assuming conversion of the maximum of up to 8,999,999 of the eligible shares of common stock) (or up to approximately $98,340,167 assuming the over-allotment option is exercised in full). We intend to structure and consummate any potential business combination in a manner such that our public stockholders holding up to 8,999,999 of our shares voting against our initial business combination could convert their shares of common stock for a pro rata share of the aggregate amount then on deposit in the trust account, and the business combination could still go forward. |
An eligible stockholder may request conversion at any time after the mailing to our stockholders of the proxy statement and prior to the vote taken with respect to a proposed business combination at a meeting held for that purpose, but the request will not be granted unless the stockholder votes against the initial business combination and the initial business combination is approved and consummated. In addition, no later than the business day immediately preceding the vote on the business combination, the stockholder must present written instructions to our transfer agent stating that the stockholder wishes to convert its shares into a pro rata share of the trust account |
and confirming that the stockholder has held the shares since the record date and will continue to hold them through the stockholder meeting and the closing of our initial business combination. We may also require public stockholders to tender their certificates to our transfer agent or to deliver their shares to the transfer agent electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System no later than the business day immediately preceding the vote on the business combination. There is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through the DWAC system. The transfer agent will typically charge the tendering broker approximately $35 and it would be up to the broker whether or not to pass this cost on to the converting holder. |
Amended
and Restated
|
|
Certificate of Incorporation: | As discussed below, there are specific provisions in our amended and restated certificate of incorporation that may not be amended prior to the consummation of our initial business combination, including our requirements to seek stockholder approval of such a business combination and to allow our stockholders to seek conversion of their shares if they do not approve of such a business combination. While we have been advised that such provisions |
|
limiting
our ability to amend our amended and restated certificate of incorporation
may not be enforceable under applicable Delaware law, we view these
provisions, which are contained in Article Sixth of our amended
and
restated certificate of incorporation, as obligations to our stockholders
and our officers and directors have agreed that they will not recommend
or
take any action to amend or waive these
provisions.
|
business
combination:
|
If
we are unable to complete a business combination prior to the date
24
months after completion of this offering, our corporate existence
will
cease except for the purposes of winding up our affairs and liquidating
pursuant to Section 278 of the Delaware General Corporation Law, in
which case we will as promptly as practicable thereafter adopt
a plan of
distribution in accordance with Section 281(b) of the Delaware
General Corporation Law. Section 278 provides that our existence will
continue for at least three years after its expiration for the
purpose of
prosecuting and defending suits, whether civil, criminal or
administrative, by
|
|
or
against us, and of enabling us gradually to settle and close our
business,
to dispose of and convey our property, to discharge our liabilities
and to
distribute to our stockholders any remaining assets, but not for
the
purpose of continuing the business for which we were organized.
Our
existence will continue automatically even beyond the three-year
period
for the purpose of completing the prosecution or defense of suits
begun
prior to the expiration of the three-year period, until such time
as any
judgments, orders or decrees resulting from such suits are fully
executed.
Section 281(b) will require us to pay or make reasonable provision
for all then-existing claims and obligations, including all contingent,
conditional, or unmatured contractual claims known to us, and to
make such
provision as will be reasonably likely to be sufficient to provide
compensation for any then-pending claims and for claims that have
not been
made known to us or that have not arisen but that, based on facts
known to
us at the time, are likely to arise or to become known to us within
10
years after the date of dissolution. Under Section 281(b), the plan
of distribution must provide for all of such claims to be paid
in full or
make provision for payments to be made in full, as applicable,
if there
are sufficient assets. If there are insufficient assets to provide
for all
such claims, the plan must provide that such claims and obligations
be
paid or provided for according to their priority and, among claims
of
equal priority, ratably to the extent of legally available assets.
These
claims must be paid or provided for before we make any distribution
of our
remaining assets to our stockholders. While we intend to pay such
claims,
if any, from the $250,000 of proceeds held outside of the trust
account
and from the $2,250,000 of interest income, after taxes, earned
on amounts
in the trust account available to us, we cannot assure you those
funds
will be sufficient to pay or provide for all creditors’ claims. Although
we will seek to have all third parties (including any vendors or
other
entities we engage after this offering) and any prospective target
businesses enter into valid and enforceable agreements with us
waiving any
right, title, interest or claim of any kind in or to any monies
held in
the trust account, there is no guarantee that they will execute
such
agreements. We have not engaged any such third parties or asked
for or
obtained any such waiver agreements at this time. There is no guarantee
that the third parties would not challenge the enforceability of
these
waivers and bring claims against the trust account for monies owed
them.
In addition, there is no guarantee that such entities will agree
to waive
any claims they may have in the future as a result of, or arising
out of,
any negotiations, contracts or agreements with us and will not
seek
recourse against the trust account for any reason. Our sponsor
and each of
our executive officers has agreed that they will be personally
liable on a
joint and several basis to ensure that the proceeds in the trust
account
are not reduced by the claims of target businesses or claims of
vendors or
other entities that are owed money by us for services rendered
or
contracted for or products sold to
us.
|
|
We
estimate that, in the event we liquidate the trust account, a public
stockholder will receive approximately $9.88 per
share,
|
|
without
taking into account interest earned on the trust account that remains
in
the trust account at such time (net of taxes payable on such interest
income and after release of up to $2,250,000 of interest income,
after
tax, to fund our working capital requirements, including the costs
of our
liquidation).
|
|
We
expect that all costs associated with implementing our plan of
liquidation
as well as payments to any creditors will be funded out of the
$250,000 of
proceeds of this offering not held in the trust account and the
up to
$2,250,000 of interest income, after taxes, on amounts in the trust
account that may be released to us. We estimate that our total
costs and expenses for implementing and completing our liquidation
will be
in the range of $15,000 to $25,000. This amount includes all
costs and expenses relating to our winding up. We believe that
there should be sufficient funds available from the proceeds not
held in
the trust account, plus interest earned on the trust account available
to
us as working capital, to fund these expenses, although we cannot
give you
assurances that these will be sufficient funds for such
purposes. If these funds are insufficient to cover the costs of
our liquidation, our sponsor and our executive officers have each
agreed,
on a joint and several basis, to indemnify us for our direct,
out-of-pocket costs associated with such liquidation and winding-up,
including litigation that would result from claimants disputing
the
validity of waivers that they have delivered, pertaining to such
liquidation.
|
Audit
Committee:
|
We
have established and will maintain an Audit Committee which initially
will
be composed of a majority of independent directors and will be
within one
year composed entirely of independent directors to, among other
things,
monitor compliance with the terms described above and the other
terms
relating to this offering and review and approve any affiliated
transactions involving our company. If any noncompliance is
identified, then the Audit Committee will be charged with responsibility
to immediately take all action necessary to rectify such noncompliance
or
otherwise to cause compliance with the terms of this
offering. For more information, see the section entitled
“Management—Committees of the Board of Directors—Audit
Committee.”
|
As
of July 13, 2007
|
||||||||
Actual
|
As
Adjusted
|
|||||||
Balance
Sheet Data:
|
||||||||
Working
capital
|
$ |
5,232
|
$ |
286,224,858
|
||||
Total
assets
|
244,037
|
296,724,858
|
||||||
Total
liabilities
|
219,768
|
10,500,000 | (1) | |||||
Value
of common stock that may be converted to cash (2)
|
-
|
85,785,167
|
||||||
Total
stockholders’ equity
|
$ |
24,269
|
$ |
200,439,691
|
||||
(1)
|
Represents
deferred underwriting discounts and commissions being held in the
trust
account ($12,075,000 if the underwriters’ over-allotment option is
exercised in full) which is payable to the underwriters upon completion
of
a business combination less $0.35 per share that the underwriters
have
agreed to forego with respect to shares public stockholders have
elected
to convert into cash pursuant to their conversion
rights.
|
(2)
|
If
the initial business combination is approved and consummated, public
stockholders who voted against the combination will be entitled
to convert
their stock for cash of approximately $9.88 per share (or up to
$88,935,167 in the aggregate), which amount represents approximately
$9.53
per share (or $85,785,167 in the aggregate) representing the net
proceeds
of the offering and $0.35 per share (or $3,150,000 in the aggregate)
representing deferred underwriting discounts and commissions which
the
underwriters have agreed to deposit into the trust account and
to forego
to pay converting stockholders, and does not take into account
interest
earned on and retained in the trust
account.
|
•
|
upon
completion of this offering, a total of $296,450,589 (or $339,875,589,
if
the underwriters’ over-allotment option is exercised in full) from the
proceeds from the offering, deferred underwriting discounts and
commissions and the proceeds of the private placement, will be
deposited
into the trust account, which proceeds may not be disbursed from
the trust
account until the earlier of (i) an initial business combination
or (ii)
our liquidation;
|
•
|
prior
to consummating our initial business combination, we must submit
such
business combination to our stockholders for
approval;
|
•
|
we
may consummate our initial business combination if (i) stockholders
owning
a majority of the shares of our common stock approve the business
combination; (ii) public stockholders owning less than 30% of the
shares
sold in this offering both vote against the business combination
and
exercise their conversion rights and (iii) our stockholders approve
an
amendment of our amended and restated certificate of incorporation
to
provide for our perpetual
existence;
|
•
|
if
our initial business combination is approved and consummated, public
stockholders who voted against the initial business combination
and who
exercised their conversion rights will receive their pro rata share
of
amounts in the trust account;
|
•
|
if
an initial business combination is not consummated within the 24
months
after the completion of this offering, then our corporate purposes
and
powers will immediately thereupon be limited to winding up our
affairs,
including liquidation of our assets, which will include funds in
the trust
account, and we will not be able to engage in any other business
activities; and
|
•
|
we
may not consummate any other merger, acquisition, capital stock
exchange,
stock purchase, asset purchase or other similar transaction other
than a
business combination that meets the conditions specified in this
prospectus, including the requirement that our initial business
combination be with one or more operating businesses whose fair
market
value, collectively, is at least equal to 80% of the balance in
the trust
account (less the deferred underwriting discounts and commissions
and
taxes payable) at the time of such business
combination.
|
•
|
the
requirement that we obtain stockholder approval of a business combination
may delay or prevent the consummation of an initial business combination
within the 24-month time period;
|
•
|
the
requirement that we prepare a proxy statement and notice of special
meeting of stockholders in accordance with the requirements of
Delaware
law and the federal securities laws, which proxy statement will
be
required to be submitted to and reviewed by the Securities and
Exchange
Commission, in connection with such business combination may delay
or
prevent the completion of a
transaction;
|
•
|
the
requirement that we prepare audited and perhaps interim-unaudited
financial information to be included in the proxy statement to
be sent to
stockholders in connection with such business combination may delay
or
prevent the consummation of a
transaction;
|
•
|
the
conversion of common stock held by our public stockholders into
cash may
reduce the resources available to us to fund our initial business
combination;
|
•
|
the
existence of our outstanding warrants, and the dilution they potentially
represent, may not be viewed favorably by certain target businesses;
and
|
•
|
the
requirement to acquire assets or an operating business that have
a fair
market value at least equal to 80% of the balance in the trust
account
(less the deferred underwriting discounts and commissions and taxes
payable) at the time of the initial business combination (i) could
require
us to acquire several assets or closely related operating businesses
at
the same time, all of which sales would be contingent on the closings
of
the other sales, which could make it more difficult to consummate
our
initial business combination and (ii) together with our ability
to proceed
with a business combination if public stockholders owning less
than 30% of
the shares sold in this offering vote against our business combination
and
exercise their conversion rights, may require us to raise additional
funds
through the private sale of securities or incur indebtedness in
order to
enable us to effect such a business
combination.
|
•
|
the
history and prospects of companies whose principal business is
the
acquisition of other businesses;
|
•
|
prior
offerings of those companies;
|
•
|
our
prospects for acquiring an operating
business;
|
•
|
our
capital structure;
|
•
|
an
assessment of our executive officers and their experience in identifying
acquisition targets and structuring
acquisitions;
|
•
|
general
conditions of the securities markets at the time of the
offering;
|
•
|
the
likely competition for target
businesses;
|
•
|
the
likely number of potential targets;
and
|
•
|
our
executive officers’ estimate of our operating expenses for the next 24
months.
|
•
|
significantly
reduce the equity interest of investors in this
offering;
|
•
|
may
subordinate the rights of holders of common stock if preferred
stock is
issued with rights senior to those afforded to our common
stock;
|
•
|
cause
a change in control which may affect, among other things, our ability
to
use our net operating loss carryforwards, if any, and result in
the
resignation or removal of our current executive officers and directors;
and
|
•
|
adversely
affect prevailing market prices for our common stock and
warrants.
|
•
|
lead
to default and foreclosure on our assets if our operating revenues
after a
business combination are insufficient to pay our debt
obligations;
|
•
|
cause
an acceleration of our obligation to repay the debt, even if we
make all
principal and interest payments when due, if we breach the covenants
contained in the terms of any debt documents, such as covenants
that
require the maintenance of certain financial ratios or reserves,
without a
waiver or renegotiation of such
covenants;
|
•
|
create
an obligation to repay immediately all principal and accrued interest,
if
any, upon demand to the extent any debt securities are payable
on
demand;
|
•
|
require
us to dedicate a substantial portion of our cash flow to pay principal
and
interest on our debt, which will reduce the funds available for
dividends
on our common stock, working capital, capital expenditures, acquisitions
and other general corporate
purposes;
|
•
|
limit
our flexibility in planning for and reacting to changes in our
business
and in the industry in which we
operate;
|
•
|
make
us more vulnerable to adverse changes in general economic, industry,
and
competitive conditions and adverse changes in government
regulation;
|
•
|
limit
our ability to borrow additional amounts for working capital, capital
expenditures, acquisitions, debt service requirements, execution
of our
strategy or other purposes; and
|
•
|
place
us at a disadvantage compared to our competitors who have less
debt.
|
•
|
a
limited availability of market quotations for our
securities;
|
•
|
a
determination that our common stock is a “penny stock” which will require
brokers trading in our common stock to adhere to more stringent
rules and
possibly result in a reduced level of trading activity in the secondary
trading market for our securities;
|
•
|
a
limited amount of news and analyst coverage;
and
|
•
|
a
decreased ability to issue additional securities or obtain additional
financing in the future.
|
•
|
make
a special written suitability determination for the
purchaser;
|
•
|
receive
the purchaser’s written agreement to a transaction prior to
sale;
|
•
|
provide
the purchaser with risk disclosure documents that identify certain
risks
associated with investing in “penny stocks” and that describe the market
for these “penny stocks,” as well as a purchaser’s legal remedies;
and
|
•
|
obtain
a signed and dated acknowledgment from the purchaser demonstrating
that
the purchaser has actually received the required risk disclosure
document
before a transaction in “penny stock” can be
completed.
|
•
|
result
in our being dependent upon the performance of a single operating
business;
|
•
|
result
in our being dependent upon the development or market acceptance
of a
single or limited number of services, processes or products;
and
|
•
|
subject
us to numerous economic, competitive and regulatory developments,
any or
all of which may have a substantial adverse impact upon the particular
industry in which we may operate subsequent to an initial business
combination.
|
•
|
inability
to predict changes in technological
innovation;
|
•
|
competition
from superior or lower priced services and
products;
|
•
|
lack
of financial resources;
|
•
|
inability
to attract and retain key executives and
employees;
|
•
|
claims
for infringement of third-party intellectual property rights and/or
the
availability of third-party licenses;
and
|
•
|
changes
in, or costs imposed by, government
regulation.
|
|
•
|
rules
and regulations or currency conversion or corporate withholding
taxes on
individuals;
|
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | longer payment cycles; |
|
•
|
tax
issues, such as tax law changes and variations in tax laws as compared
to
the United States;
|
• | currency fluctuations and exchange controls; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | crime, strikes, riots, civil disturbances, terrorist attacks and wars; and |
• | deterioration of political relations with the United States. |
•
|
corporate
governance requirements and requirements regarding mergers and
share
exchanges;
|
•
|
restrictions
on the nature of our investments;
|
•
|
restrictions
on our capital structure and use of multiple classes of securities;
and
|
•
|
restrictions
on our use of leverage and
collateral;
|
•
|
registration
as an investment company;
|
•
|
adoption
of a specific form of corporate structure;
and
|
•
|
reporting,
record keeping, voting, proxy, and disclosure requirements, and
other
rules and regulations;
|
•
|
expectations
regarding competition for business combination
opportunities;
|
•
|
beliefs
regarding the types of businesses that we can purchase with the
proceeds
from this offering;
|
•
|
expectations
regarding the prioritization of the fiduciary duties of our executive
officers and directors with respect to the allocation of business
opportunities and the consummation of any business
combination;
|
•
|
expectations
regarding the involvement of our executive officers following a
business
combination;
|
•
|
estimate
regarding the operating expenses of our business before and after
the
consummation of an initial business combination and our expectation
that
we may require additional financing to fund the operations or growth
of
the target business or businesses;
|
•
|
expectations
regarding the waiver of any right, title, interest or claim of
any kind in
or to any monies held in the trust account by all vendors, prospective
target businesses or other entities we do business
with;
|
•
|
belief
that upon completion of the private placement and this offering,
we will
have sufficient funds to operate for at least the next 24 months,
assuming
that an initial business combination is not consummated during
that
time;
|
•
|
expectations
regarding the timing of generating any
revenues;
|
•
|
expectations
regarding the trading of the units, common stock and warrants on
the
American Stock Exchange;
|
•
|
intention
to make liquidating distributions to our stockholders as soon as
reasonably possible if we have not consummated our initial business
combination and we are obligated to terminate our corporate existence
24
months after the completion of this offering;
and
|
•
|
plan
to seek stockholder approval before we consummate our initial business
combination.
|
Without
Over-Allotment Option
|
With
Over-Allotment Option
|
|||||||
Gross
Proceeds
|
||||||||
Offering
|
$ |
300,000,000
|
$ |
345,000,000
|
||||
Private
placement
|
8,000,000
|
8,000,000
|
||||||
Total
Gross Proceeds
|
$ |
308,000,000
|
$ |
353,000,000
|
||||
Offering
expenses (1)
|
||||||||
Underwriting
discount (7% of gross proceeds of the offering) (2)
|
21,000,000
|
24,150,000
|
||||||
Legal
fees and expenses
|
400,000
|
400,000
|
||||||
Printing
and engraving expenses
|
90,000
|
90,000
|
||||||
Accounting
fees and expenses
|
60,000
|
60,000
|
||||||
SEC
registration fee
|
18,536
|
18,536
|
||||||
FINRA
filing fee
|
60,875
|
60,875
|
||||||
AMEX
listing fee
|
70,000
|
70,000
|
||||||
Miscellaneous
expenses
|
100,000
|
100,000
|
||||||
Total
offering expenses
|
$ |
21,799,411
|
$ |
24,949,411
|
||||
Net
proceeds after offering expenses
|
286,200,589
|
328,050,589
|
||||||
Net
offering proceeds not held in the trust account
|
250,000
|
250,000
|
||||||
Net
proceeds held in the trust account for our benefit
|
$ |
285,950,589
|
$ |
327,800,589
|
||||
Deferred
underwriting discounts held in the trust account
|
10,500,000
|
12,075,000
|
||||||
Total
amount in the trust account
|
$ |
296,450,589
|
$ |
339,875,589
|
||||
Percentage
of the gross proceeds of the offering held in the trust
account
|
98.8 | % | 98.5 | % | ||||
Use
of net proceeds not held in the trust account and amounts available
from
interest income earned after tax on the trust
account
|
||||||||
Legal,
accounting and other expenses attendant to the structuring and
negotiation
of a business combination
|
$ |
800,000
|
||||||
Due
diligence and investigation of prospective target business
(3)
|
800,000
|
|||||||
Legal
and accounting fees relating to SEC reporting obligations
|
50,000
|
|||||||
Administrative
fees relating to office space and administrative services ($7,500
per
month for 2 years)
|
180,000
|
|||||||
Director
and officer insurance
|
300,000
|
|||||||
Corporate
franchise taxes
|
120,000
|
|||||||
Working
capital to cover potential deposits, down payments, exclusivity
fees,
finder’s fees, or similar fees or compensation, reserves, costs and
expenses associated with our liquidation , and other miscellaneous
expenses not yet identified (4)
|
250,000
|
|||||||
Total
|
$ |
2,500,000
|
(1) | A portion of the offering expenses have been paid from the funds we received in the form of a loan from NRDC Capital Management, LLC as described below. This loan will be repaid out of the proceeds of this offering. |
(2)
|
Includes
deferred underwriting discounts and commissions equal to 3.5% of
the gross
proceeds from the sale of the units to the public stockholders,
or
$10,500,000 ($12,075,000 if the underwriters’ over-allotment option is
exercised in full), which will be deposited in the trust account
and which
the underwriters have agreed to defer until the consummation of
our
initial business combination. If we consummate an initial
business combination, $10,500,000 ($12,075,000 if the underwriters’
over-allotment option is exercised in full) will be paid to the
underwriters as deferred underwriting discounts and commissions
(subject
to a $0.35 per share reduction for public stockholders who exercise
their
conversion rights). See the section entitled
“Underwriting—Discounts and
Commissions.”
|
(3)
|
These
expenses include any reimbursements to be made to our executive
officers
and directors for out-of-pocket expenses incurred by them in performing
due diligence and activities in connection with the evaluation
of a
potential business combination, as well as any potential fees that
we may
pay to third parties, such as market research firms and other consultants,
that perform due diligence of a target business on our behalf (other
than
to the extent such fees are paid by our executive officers and
directors
on our behalf and such persons are reimbursed in the amount and
to the
extent of such fees).
|
(4)
|
The
not yet identified miscellaneous expenses include, without limitation,
the
reimbursement of our executive officers and directors for out-of-pocket
expenses in connection with this offering, such as roadshow expenses
and
advances for offering costs made by them and not covered by the
amounts
set aside for offering expenses set forth on the table above and
costs and
expenses associated with our
liquidation.
|
As
of July 13, 2007
|
||||||||
Actual
|
As
Adjusted
|
|||||||
Note
payable
|
$ |
200,000
|
—
|
|||||
Total
debt (1)
|
$ |
200,000
|
—
|
|||||
Common
stock, $0.0001 par value, 0 and 8,999,999 shares which are subject
to
possible conversion, shares at conversion value (2)
|
$ |
—
|
$ |
85,785,167
|
||||
Stockholders’
equity (deficit):
|
||||||||
Preferred
stock, $0.0001 par value, 5,000 shares authorized; none issued
or
outstanding
|
$ |
—
|
$ |
—
|
||||
Common
stock, $0.0001 par value, 106,000,000 shares authorized; 8,625,000
shares
issued and outstanding – actual; 28,500,001 shares issued and outstanding
– as adjusted (excluding 8,999,999 shares subject to possible
conversion)
|
$ |
862
|
$ | 2,850 | (3) | |||
Additional
paid-in capital
|
24,138
|
200,437,572
|
||||||
Deficit
accumulated during the development stage
|
(731 | ) | (731 | ) | ||||
Total
stockholders’ equity
|
$ |
24,269
|
$ |
200,439,691
|
||||
Total
capitalization
|
$ |
224,269
|
$ |
286,224,858
|
||||
(1)
|
Assumes
payment of, and therefore excludes, deferred underwriting discounts
and
commissions equal to 3.5% of the gross proceeds, or $10,500,000
($12,075,000 if the underwriters’ over-allotment option is exercised in
full), which will be deposited in the trust account and which the
underwriters have agreed to defer until the consummation of our
initial
business combination. See the section entitled
“Underwriting—Discounts and
Commissions.”
|
(2)
|
If
we consummate an initial business combination, the conversion rights
afforded to our public stockholders, other than our executive officers,
directors and existing stockholders, may result in the conversion
into
cash of up to 8,999,999 shares sold in this offering at a per share
conversion price equal to the amount in the trust account (including
the
amount representing the deferred portion of the underwriting discounts
and
commissions), inclusive of any interest thereon (net of taxes payable
on
such interest income and after release of up to $2,250,000 of interest
income, after tax, to fund working capital requirements), as of
two
business days prior to the proposed consummation of a business
combination, divided by the number of shares sold in this
offering.
|
(3)
|
Assumes
that the underwriters’ over-allotment option is not exercised and that
1,125,000 shares sold to our sponsor that are subject to forfeiture
to the
extent the underwriters do not exercise their over-allotment option
have
been forfeited.
|
Initial
public offering price
|
$
10.00
|
|
Net
tangible book value (deficit) before this offering and the private
placement
|
$ 0.00
|
|
Increase
attributable to new investors in this offering and the private
placement
|
7.03
|
|
Pro
forma net tangible book value after this offering and the private
placement
|
$ 7.03
|
|
Dilution
to new investors
|
$ 2.97
|
|
Numerator:
|
|||||
Net
tangible book value before this offering and the private
placement
|
$ 5,232
|
||||
Offering
costs incurred in advance and excluded from net tangible book
value
|
19,037
|
||||
Net
Proceeds from this offering and the private placement including
deferred
underwriting costs
|
296,700,589
|
||||
Less: Deferred
underwriting costs excluded from net tangible book value before
this
offering and the private placement(1)
|
(10,500,000)
|
||||
Less:
Proceeds held in the trust account subject to conversion to
cash
|
(85,785,167)
|
||||
Total
net tangible book value after this offering and the private
placement
|
$200,439,691
|
||||
Denominator:
|
|||||
Shares
of common stock outstanding prior to this offering and the private
placement(2)
|
7,500,000
|
||||
Shares
of common stock included in the units offered in this offering
and the
private placement
|
30,000,000
|
||||
Less:
Shares subject to conversion(3)
|
(8,999,999)
|
||||
Total
shares of common stock
|
28,500,001
|
||||
(1)
|
The
deferred underwriting discounts and commissions are subject to
a $0.35 per
share reduction for stockholders who exercise their conversion
rights.
|
(2)
|
Does
not include 1,125,000 shares sold to our sponsor that are subject
to
forfeiture to the extent the underwriters do not exercise their
over-allotment option.
|
(3)
|
This
table notes that we may be required to convert up to a maximum
of
8,999,999 shares to cash in connection with our initial business
combination.
|
Shares
Purchased
|
Total
Consideration (1)
|
Average
Price Per Share
|
|||||||
Number
|
Percentage
|
Amount
|
Percentage
|
||||||
Existing
stockholders(2)
|
7,500,000
|
20%
|
$25,000
|
0.01%
|
$ 0.003
|
||||
Public
Stockholders
|
30,000,000
|
80%
|
300,000,000
|
99.99%
|
$10.000
|
||||
Total
|
37,500,000
|
100%
|
$300,025,000
|
100.00%
|
|||||
(1)
|
Total
consideration includes consideration paid for warrants as well
as shares
of common stock, included in the units issued in the
offering.
|
(2)
|
Does
not include 1,125,000 shares sold to our sponsor that are subject
to
forfeiture to the extent the underwriters do not exercise their
over-allotment option.
|
•
|
may
significantly reduce the equity interest of our
stockholders;
|
•
|
will
likely cause a change in control if a substantial number of our
shares of
common stock or voting preferred stock are issued which may affect,
among
other things, our ability to use our net operating loss carry forwards,
if
any, and also may result in the resignation or removal of one or
more of
our current executive officers and
directors;
|
•
|
may
subordinate the rights of holders of common stock if we issue preferred
stock with rights senior to those afforded to our common
stock;
|
•
|
may
have the effect of delaying or preventing a change of control of
us by
diluting the stock ownership or voting rights of a person seeking
to
obtain control of us; and
|
•
|
may
adversely affect prevailing market prices for our common
stock.
|
•
|
lead
to default and foreclosure on our assets if our operating revenues
after a
business combination are insufficient to pay our debt
obligations;
|
•
|
cause
an acceleration of our obligations to repay the debt, even if we
make all
principal and interest payments when due, if we breach the covenants
contained in the terms of the debt documents, such as covenants
that
require the maintenance of certain financial ratios, without a
waiver or
renegotiation of such covenants;
|
•
|
create
an obligation to repay immediately all principal and accrued interest,
if
any, upon demand to the extent any debt securities are payable
on demand;
and
|
•
|
hinder
our ability to obtain additional financing, if necessary, to the
extent
any debt securities contain covenants restricting our ability to
obtain
additional financing while such security is outstanding, or to
the extent
our existing leverage discourages other potential
investors.
|
•
|
approximately
$800,000 of expenses for legal and accounting fees relating to
the
structuring and negotiating of our initial business
combination;
|
•
|
approximately
$800,000 of expenses and fees relating to the due diligence investigation
of potential target businesses;
|
•
|
approximately
$50,000 of expenses in legal and accounting fees relating to our
SEC
reporting obligations;
|
•
|
approximately
$180,000 of expenses in fees relating to our office space and certain
general and administrative
expenses;
|
•
|
approximately
$300,000 for director and officer
insurance;
|
•
|
approximately
$120,000 for corporate franchise taxes;
and
|
•
|
approximately
$250,000 for general working capital that will be used for other
expenses,
including costs and expenses associated with our liquidation (which
we
estimate will be in the range of $15,000 to $25,000), if necessary,
and
reserves.
|
•
|
An
Established Business with a Proven Operating Track
Record. We will seek established businesses with records
of strong financial performance and sound operating results, or
ones which
our management team believes have the potential for positive operating
cash flow. It is not our intention to acquire a start-up
company.
|
•
|
Strong
Industry Position. We will seek to acquire strong
competitors in industries with appealing prospects for future growth
and
profitability. We will examine the ability of these target businesses
to
defend and improve their advantages in areas such as customer base,
branding, intellectual property, vendor relationships, working
capital and
capital investments.
|
•
|
Experienced
Management Team. We will concentrate on target businesses
with an experienced management team that has created an effective
corporate culture and utilized best business practices in areas
such as
customer service, vendor relationships, recruiting and
retention.
|
•
|
Ability
For Us To Add Value. We will seek a target company where
our management team has identified opportunities to improve the
operating
business through the implementation of marketing, operational,
growth and
management strategies to augment the company’s existing
capabilities.
|
•
|
Underlying
Real Estate Value. Given the inherent skills and
experience of our management team, we will focus initially on operating
businesses where we have the opportunity to create value from the
real
estate underlying the business.
|
•
|
subject
us to negative economic, competitive, and regulatory developments,
any or
all of which may have a substantial adverse impact on the particular
industry in which we operate after an initial business
combination;
|
•
|
cause
us to depend on the marketing and sale of a single service or product
or
limited number of services or products;
and
|
•
|
result
in our dependency upon the performance of a single operating
business.
|
•
|
the
requirement that we obtain stockholder approval of our initial
business
combination and that audited and perhaps interim-unaudited financial
information be included in the proxy statement to be sent to stockholders
in connection with such business combination may delay or prevent
the
consummation of a transaction;
|
•
|
the
conversion of common stock held by our public stockholders into
cash may
reduce the resources available to us to fund an initial business
combination;
|
•
|
our
outstanding warrants, the private placement warrants and the co-investment
securities and the dilution they potentially represent, may not
be viewed
favorably by certain target businesses;
and
|
•
|
the
requirement to acquire assets or an operating business that has
a fair
market value at least equal to 80% of the balance in the trust
account
(less the deferred underwriting discounts
and
|
|
commissions
and taxes payable) at the time of the initial business combination
could
require us to acquire several assets or closely related operating
businesses at the same time, all of which sales would be contingent
on the
closings of the other sales, which could make it more difficult
to
consummate the initial business
combination.
|
Terms
of
Our
Offering
|
Terms
Under a
Rule
419 Offering
|
||
Escrow
of offering proceeds
|
$296,450,589
of the net proceeds from this offering and the private placement
will be
deposited in a trust account at JPMorgan Chase Bank, N.A., maintained
by
Continental Stock Transfer & Trust Company, as
trustee. These proceeds consist of $277,950,589 from the net
proceeds of the offering, $10,500,000 of proceeds attributable
to the
deferred underwriting discounts and commissions and $8,000,000
of proceeds
from the private placement.
|
$251,100,000
of the offering proceeds would be required to be deposited into
either an
escrow account with an insured depositary institution or in a separate
bank account established by a broker-dealer in which the broker-
dealer
acts as trustee for persons having the beneficial interests in
the
account.
|
|
Investments
of net proceeds
|
The
$296,450,589 of net proceeds from this offering and the private
placement
held in the trust account will only be invested in United States
“government securities” within the meaning of Section 2(a)(16) of the 1940
Act with a maturity of 180 days or less or in a money market funds
meeting
conditions under Rule 2a-7 promulgated under the 1940 Act.
|
Proceeds
could be invested only in specified securities such as a money
market fund
meeting conditions of the 1940 Act or in securities that are direct
obligations of, or obligations guaranteed as to principal or interest
by,
the United States.
|
|
Stockholder
right to receive interest earned from funds held in the trust
account
|
Interest
earned on funds held in the trust account (net of taxes payable
on such
interest income and after release of up to $2,250,000 of interest
income,
after tax, to fund working capital requirements, including the
costs of
our liquidation in such an event) will be held in the trust account
for
use in consummating an initial business combination or released
to
investors upon exercise of their conversion rights or upon liquidation
.
|
Interest
or dividends earned on the funds, if any, shall be held in the
escrow or
trust account until the funds are released in accordance with Rule
419. Proceeds held in the escrow account would not be released
until the earlier of the consummation of an initial business combination
or the failure to consummate an initial business combination within
the
allotted time. If funds held in the escrow or trust account are
released to a purchaser of the securities, the purchaser shall
receive
interest or dividends earned, if any, on such funds up to the date
of
release. If
|
Terms
of
Our
Offering
|
Terms
Under a
Rule
419 Offering
|
|
|
funds
held in the escrow or trust account are released to the registrant,
interest or dividends earned on such funds up to the date of release
may
be released to the registrant.
|
Limitation
on fair value or net assets of target business
|
The
target for our initial business combination must have a fair market
value
equal to at least 80% of the balance in the trust account (less
the
deferred underwriting discounts and commissions and taxes payable)
at the
time of such business combination. If we acquire less than 100%
of one or more target businesses in our initial business combination,
the
aggregate fair market value of the portion or portions we acquire
must
equal at least 80% of the balance in the trust account (excluding
deferred
underwriting discounts and commissions as described above) at the
time of
such initial business combination. The fair market value of a portion
of a
target business will be calculated by multiplying the fair market
value of
the entire business by the percentage of the target business we
acquire.
|
The
fair value or net assets of a target business must represent at
least 80%
of the maximum offering proceeds.
|
|
Trading
of securities issued
|
The
units will begin trading on or promptly after the date of this
prospectus. The common stock and warrants comprising the units
will begin trading separately five (5) business days following
the earlier
to occur of termination of the underwriters’ over-allotment option or its
exercise in full.
|
No
trading of the units or the underlying common stock and warrants
would be
permitted until the consummation of an initial business
combination. During this period, the securities would be held
in the escrow or trust account.
|
|
In
no event will the common stock and warrants be traded separately
until we
have filed a Current Report on Form 8-K with the SEC containing
an audited
balance sheet reflecting our receipt of the gross proceeds of this
offering, including proceeds from exercise of the over-allotment
option if
such option has
|
Terms
of
Our
Offering
|
Terms
Under a
Rule
419 Offering
|
then
been exercised. We will file this Form 8-K upon the completion
of this offering. If the over-allotment option is exercised
following the initial filing of such Form 8-K, an additional Current
Report on Form 8-K will be filed to provide updated financial information
to reflect the exercise of the over-allotment option.
|
Exercise
of the warrants
|
The
warrants (excluding the co-investment warrants) cannot be exercised
until
the later of the consummation of an initial business combination
or one
year from the completion of this offering (assuming in each case
that
there is an effective registration statement covering the shares
of common
stock underlying the warrants in effect) and, accordingly, will
only be
exercised after the trust account has been terminated and
distributed.
|
The
warrants could be exercised prior to the consummation of an initial
business combination, but securities received and cash paid in
connection
with the exercise would be deposited in the escrow or trust
account.
|
|
Election
to remain an investor
|
Stockholders
will have the opportunity to vote on the initial business
combination. Each stockholder will be sent a proxy statement
containing information required by the SEC. If our shares are
listed on AMEX, the meeting to vote on the initial business combination
will take place not less than 23 days after mailing the proxy
statement. If our shares are not listed on AMEX, the meeting to
vote on the initial business combination will take place not less
than 10
days after the certification date of mailing the proxy
statement. A stockholder following the procedures described in
this prospectus is given the right to convert his, her or its shares
into
a pro rata share of the trust account, including accrued interest
(net of
taxes payable on such interest income and after release of up to
$2,250,000 of interest income, after tax, to fund working capital
requirements). However, a
|
A
prospectus containing information required by the SEC would be
sent to
each investor. Each investor would be given the opportunity to
notify the company in writing, within a period of no less than
20 business
days and no more than 45 business days from the effective date
of a
post-effective amendment to the company’s registration statement, to
decide if he, she, or it elects to remain a stockholder of the
company or
require the return of his, her, or its investment. If the
company has not received the notification by the end of the 45th
business
day, funds and interest or dividends, if any, held in the trust
or escrow
account are automatically returned to the stockholder. Unless a
sufficient number of investors elect to remain investors, all funds
on
deposit in the escrow account must be returned to all of the investors
and
|
Terms
of
Our
Offering
|
Terms
Under a
Rule
419 Offering
|
|
stockholder
who does not follow these procedures or a stockholder who does
not take
any action, including abstaining from the vote, would not be entitled
to
the return of any funds from the trust account. A quorum of our
stockholders must vote on the initial business
combination. Abstentions are not considered to be voting “for”
or “against” a transaction and will have no effect on the outcome of the
vote to approve our initial business combination. If a majority
of the shares of common stock voted by the public stockholders
are not
voted in favor of a proposed initial business combination but 24
months
have not yet passed since the completion of this offering, we may
seek
other target businesses that meet the criteria set forth in this
prospectus with which to consummate our initial business
combination. If at the end of such 24 month period we have not
obtained stockholder approval for an alternate initial business
combination, we will liquidate and promptly distribute the proceeds
of the
trust account, including accrued interest (net of taxes payable
on such
interest income, and after release of up to $2,250,000 of interest
income,
after tax, to fund working capital requirements).
|
none
of the securities are issued.
|
Terms
of
Our
Offering
|
Terms
Under a
Rule
419 Offering
|
Initial
business combination deadline
|
Pursuant
to our amended and restated certificate of incorporation, our corporate
existence will cease 24 months from the completion of this offering
except
for the purposes of winding up our affairs and we will
liquidate. However, if we complete our initial business
combination within this time period, we will amend this provision
to allow
for our perpetual existence following such business
combination.
If
we are unable to complete a business combination within 24 months
after
the completion of this offering, our existence will automatically
terminate and as promptly as practicable thereafter the trustee
will
commence liquidating the investments constituting the trust account
and
distribute the proceeds to our public stockholders, including any
interest
earned on the trust account not used to cover liquidation expenses,
net of
income taxes payable on such interest and after distribution to
us of
interest income on the trust account balance as described in this
prospectus.
|
If
an initial business combination has not been consummated within
18 months
after the effective date of the company’s registration statement, funds
held in the trust or escrow account are returned to
investors.
|
|
Release
of funds held in the trust account
|
Except
with respect to interest income earned on the trust account balance
released to us to pay any income taxes on such interest and interest
income of up to $2,250,000 million on the balance in the trust
account
released to us to fund our working capital requirements (subject
to the
payment of taxes on such interest), the proceeds held in the trust
account
will not be released to us until the earlier of the completion
of our
initial business combination or the failure to complete our initial
business combination within the allotted time.
|
The
proceeds held in the escrow account are not released until the
earlier of
the consummation of an initial business combination or the failure
to
consummate an initial business combination within the allotted
time. Liquidation will require stockholder approval
of a plan of liquidation approved by our board of directors prior
to
releasing the proceeds held in the escrow account. However,
since all securities are required to be held in the escrow or trust
account, liquidation will not require solicitation of public stockholders
or compliance with the SEC proxy rules. In the event an initial
business combination is not consummated within 18 months,
|
Terms
of
Our
Offering
|
Terms
Under a
Rule
419 Offering
|
|
|
proceeds
held in the trust account would be returned within 5 business days
of such
date.
|
Name:
|
Age:
|
Position:
|
William
L. Mack
|
67
|
Chairman
of the Board
|
Robert
C. Baker
|
72
|
Vice-Chairman
of the Board
|
Richard
A. Baker
|
41
|
Chief
Executive Officer and Director
|
Lee
Neibart
|
57
|
President
and Director
|
Michael
J. Indiveri
|
56
|
Director
|
Edward
H. Meyer
|
80
|
Director
|
Laura
Pomerantz
|
60
|
Director
|
Vincent
Tese
|
64
|
Director
|
Ronald
W. Tysoe
|
54
|
Director
|
•
|
meeting
with our independent accountants regarding, among other issues,
audits,
and adequacy of our accounting and control
systems;
|
•
|
monitoring
the independence of the independent
auditor;
|
•
|
verifying
the rotation of the lead (or coordinating) audit partner having
primary
responsibility for the audit and the audit partner responsible
for
reviewing the audit as required by
law;
|
•
|
inquiring
and discussing with management our compliance with applicable laws
and
regulations;
|
•
|
pre-approving
all audit services and permitted non-audit services to be performed
by our
independent auditor, including the fees and terms of the services
to be
performed;
|
•
|
appointing
or replacing the independent
auditor;
|
•
|
determining
the compensation and oversight of the work of the independent auditor
(including resolution of disagreements between management and the
independent auditor regarding financial reporting) for the purpose
of
preparing or issuing an audit report or related
work;
|
•
|
establishing
procedures for the receipt, retention and treatment of complaints
received
by us regarding accounting, internal accounting controls or reports
which
raise material issues regarding our financial statements or accounting
policies;
|
•
|
monitoring
compliance on a quarterly basis with the terms of this offering
and, if
any noncompliance is identified, immediately taking all action
necessary
to rectify such noncompliance or otherwise causing compliance with
the
terms of this offering; and
|
•
|
reviewing
and approving all payments made to our existing stockholders, sponsors,
officers or directors and their respective affiliates, other than
a
payment of an aggregate of $7,500 per month to our sponsor for
office
space and administrative services. Any payments made to members
of our
Audit Committee will be reviewed and approved by our board of directors,
with the interested director or directors abstaining from such
review and
approval.
|
•
|
Establishing
overall employee compensation policies and recommending to our
board of
directors major compensation
programs;
|
•
|
Subsequent
to our consummation of a business combination, reviewing and approving
the
compensation of our officers and directors, including salary and
bonus
awards;
|
•
|
Administering
our various employee benefit, pension and equity incentive
programs;
|
•
|
Reviewing
officer and director indemnification and insurance matters;
and
|
•
|
Following
the completion of this offering, preparing an annual report on
executive
compensation for inclusion in our proxy
statement.
|
•
|
None
of our executive officers and directors is required to commit his
full
time to our affairs and, accordingly, they may have conflicts of
interest
in allocating management time among various business
activities. Each of our executive officers and directors is
engaged in several other business endeavors. Our executive
officers and directors are not obligated to contribute any specific
number
of hours per week to our affairs.
|
•
|
In
the course of their other business activities, our executive officers
and
directors may become aware of investment and business opportunities
that
may be appropriate for presentation to us as well as the other
entities
with which they are affiliated. They may have conflicts of
interest in determining to which entity a particular business opportunity
should be presented. For a complete description of our
executive officers’ and directors’ other affiliations, see the section
entitled “Management.” We and they have determined to deal with these
potential conflicts as discussed
below.
|
•
|
Our
executive officers and directors are, and may in the future become,
affiliated with entities engaged in business activities similar
to those
intended to be conducted by us but have agreed not to become affiliated
with any other blank check companies until the earlier of our consummation
of an initial business combination or our
liquidation.
|
•
|
We
may decide to acquire one or more businesses affiliated with our
executive
officers, directors or existing stockholders. Despite our
agreement to obtain an opinion from an independent investment banking
firm
that a business combination with one or more businesses affiliated
with
our executive officers, directors or existing stockholders is fair
to our
stockholders from a financial point of view, potential conflicts
of
interest may still exist, and as a result, the terms of our initial
business combination may not be as advantageous to our public stockholders
as it would be absent any conflicts of
interest.
|
•
|
The
personal and financial interests of our executive officers and
directors
may influence their motivation in identifying and selecting target
businesses and consummating an initial business combination in
a timely
manner. These interests include membership interests held by
our executive officers, all of whom are also directors, in our
sponsor,
and through those interests an indirect ownership in our common
stock,
private placement warrants and co-investment securities held
by our
sponsor. Our executive officers, directors and existing
stockholders have entered into a lock-up agreement with the underwriters.
Under the terms of this agreement, our executive officers, directors
and
existing stockholders have agreed not to enter into any agreement
to sell
or transfer any of their common stock held prior to the completion
of this
offering, if any, until one year after the consummation of our
initial
business combination, and any of their private placement warrants,
if any,
until after the consummation of our initial business combination,
subject
to certain exceptions described under the section entitled “Underwriting –
Lock-up Agreement.”
|
•
|
It
is possible that Messrs Mack, Robert Baker, Richard Baker and Neibart,
as
our executive officers, could be negotiating the terms and conditions
of
the business combination on our behalf at the same time that they,
as
individuals, were negotiating the terms and conditions related
to an
employment, consulting or other agreement with representatives
of the
potential business combination
candidate.
|
•
|
Our
sponsor has agreed that, commencing on the effective
date of this prospectus it will make available to us office space
and
certain general and administrative services, as we may
require
|
|
from
time to time. We have agreed to pay our sponsor, $7,500 per
month for these services. As a result of this agreement, our
executive officers will benefit from the transaction to the extent
of
their indirect interest in our sponsor. However, these
arrangements are solely for our benefit and are not intended to
provide
any of our executive officers or directors compensation in lieu
of a
salary. We believe, based on rents and fees for similar office
space and services in the Purchase, New York area, that the fees
charged
by our sponsor, are at least as favorable as we could have obtained
from
unaffiliated third-parties.
|
•
|
the
corporation could financially undertake the
opportunity;
|
•
|
the
opportunity is within the corporation’s line of business;
and
|
•
|
it
would not be fair to the corporation and its stockholders for the
opportunity not to be brought to the attention of the
corporation.
|
•
|
each
person known by us to be the beneficial owner of more than 5% of
our
outstanding shares of common stock;
|
•
|
each
of our executive officers and directors;
and
|
•
|
all
of our executive officers and directors as a
group.
|
As
Adjusted for the Public Offering
|
||||||
No
Exercise of
Over-allotment
Option
|
Full
Exercise of
Over-allotment
Option
|
|||||
Name
of Beneficial Owners(1)
|
Number
of Shares before Offering and Private
Placement
|
Percentage
of Outstanding Common Stock
|
Number
of Shares
|
Percentage
of Outstanding Common Stock
|
Number
of Shares
|
Percentage
of Outstanding Common Stock
|
NRDC
Capital Management, LLC(2)(6)
|
8,400,000
|
100.00%
|
7,275,000
|
20.00%
|
8,400,000
|
20.00%
|
William
L. Mack(2)(3)(5)
|
8,400,000
|
100.00%
|
7,275,000
|
20.00%
|
8,400,000
|
20.00%
|
Robert
C. Baker(2)(3)(4)(5)
|
8,400,000
|
100.00%
|
7,275,000
|
20.00%
|
8,400,000
|
20.00%
|
Richard
A. Baker(2)(3)(4)(5)
|
8,400,000
|
100.00%
|
7,275,000
|
20.00%
|
8,400,000
|
20.00%
|
Lee
Neibart(3)(5)
|
8,400,000
|
100.00%
|
7,275,000
|
20.00%
|
8,400,000
|
20.00%
|
Michael
J. Indiveri
|
45,000
|
0.52%
|
45,000
|
*
|
45,000
|
*
|
Edward
H. Meyer
|
45,000
|
0.52%
|
45,000
|
*
|
45,000
|
*
|
Laura
Pomerantz
|
45,000
|
0.52%
|
45,000
|
*
|
45,000
|
*
|
Vincent
Tese
|
45,000
|
0.52%
|
45,000
|
*
|
45,000
|
*
|
Ronald
W. Tysoe
|
45,000
|
0.52%
|
45,000
|
*
|
45,000
|
*
|
All
Directors and Officers as a Group (9 persons)
|
8,625,000
|
100.00%
|
7,500,000
|
20.00%
|
8,625,000
|
20.00%
|
(1)
|
Unless
otherwise noted, the business address of each of the following
is 3
Manhattanville Road, Purchase, New York
10577.
|
(2)
|
NRDC
Real Estate Advisors, LLC, as the sole member of our sponsor, may
be
deemed to be the beneficial owner of the shares of common stock
held by
our sponsor. William L. Mack, Robert C. Baker, Richard A. Baker
and Lee S. Neibart, as the members of NRDC Real Estate Advisors,
LLC, may
be deemed to be the beneficial owners of the shares of common stock
held
by NRDC Real Estate Advisors, LLC. Includes 1,125,000 shares of
common stock that are subject to forfeiture to the extent the underwriters
do not exercise their over-allotment
option.
|
(3)
|
Includes
shares issued to our sponsor. See footnote (2)
above.
|
(4)
|
Mr.
Robert C. Baker and Mr. Richard A. Baker are father and son, but
do not
share the same residence.
|
(5)
|
Upon
consummation of the co-investment, our sponsor would own approximately
24.1% of our outstanding common stock, assuming that no additional
shares
are otherwise issued as consideration for our initial business
combination
and that our sponsor does not purchase any additional shares
of our common
stock in this offering or after completion of this
offering.
|
•
|
the
consummation of the initial business combination;
or
|
•
|
one
year from the completion of this
offering.
|
•
|
The
warrants will expire four years from the completion of this offering
at
5:00 p.m., New York City time. We may call the warrants for
redemption at any time after the warrants become
exercisable:
|
•
|
in
whole and not in part;
|
•
|
at
a price of $0.01 per warrant;
|
•
|
upon
a minimum of 30 days’ prior written notice to each warrant holder;
and
|
•
|
if,
and only if, the last sales price of our common stock on the American
Stock Exchange, or other principal market on which our common stock
may be
traded, equals or exceeds $14.25 per share for any 20 trading days
within
a 30 trading day period ending three business days before we send
the
notice of redemption to warrant holders, and a registration statement
under the Securities Act relating to shares of common stock issuable
upon
exercise of the warrants is effective and expected to remain effective
and
a prospectus is available for use to and including the redemption
date.
|
•
|
1%
of the number of shares of common stock then outstanding, which
will equal
375,000 shares immediately after this offering (or 431,250 if the
underwriters exercise their over-allotment option in full);
and
|
•
|
the
average weekly trading volume of the common stock during the four
calendar
weeks preceding the filing of a notice on Form 144 with respect
to the
sale.
|
•
|
Stockholders
equity of at least $4.0 million;
|
•
|
Total
market capitalization of at least $50.0
million;
|
•
|
Aggregate
market value of publicly held shares of at least $15.0
million;
|
•
|
Minimum
public distribution of at least 1,000,000 units with a minimum
of 400
public holders; and
|
•
|
A
minimum market price of $2.00 per
unit.
|
Underwriters
|
|
Number of Units
|
Banc
of America Securities LLC
|
|
|
|
|
|
Total
|
|
30,000,000
|
•
|
receipt
and acceptance of the units by the underwriters;
and
|
•
|
the
underwriters’ right to reject orders in whole or in
part.
|
|
|
Paid
by Us
|
||||
Underwriting
Discount
|
|
No Exercise
|
|
Full Exercise
|
||
Per
Unit (1)
|
|
$0.35
|
|
$0.35
|
||
Total
(1)
|
|
$10,500,000
|
|
$12,075,000
|
||
(1)
|
The
total underwriting discount as a percentage of the gross offering
proceeds
is equal to 4.0%. This amount excludes deferred underwriting
discounts and
commissions equal to 3.5% of the gross proceeds, or $10,500,000
($12,075,000 if the underwriters’ over-allotment option is exercised in
full), or $0.35 per unit, which will be deposited in the trust
account and
which the underwriters have agreed to defer until the consummation
of our
initial business combination. These funds (less the amounts the
underwriters have agreed to forego with respect to any shares
public
stockholders convert into cash pursuant to their conversion rights)
will
be released to the underwriters upon consummation of our initial
business
combination. If we do not consummate an initial business combination,
the
deferred underwriting discounts and commissions will not be paid
to the
underwriters and the full amount plus the retained interest thereon
will
be included in the amount available to our public stockholders
upon our
liquidation.
|
•
|
stabilizing
transactions;
|
•
|
short
sales;
|
•
|
syndicate
covering transactions;
|
•
|
imposition
of penalty bids; and
|
•
|
purchases
to cover positions created by short
sales.
|
•
|
the
history of, and prospects for companies whose principal business
is the
acquisition of other businesses;
|
•
|
prior
offerings of those companies;
|
•
|
our
prospects for acquiring an operating business at attractive
values;
|
•
|
our
capital structure;
|
•
|
an
assessment of our executive officers and their experience in
identifying
target businesses and structuring
acquisitions;
|
•
|
general
conditions of the securities markets at the time of the
offering;
|
•
|
the
likely competition for target
businesses;
|
•
|
the
likely number of potential targets;
and
|
•
|
our
executive officers’ estimate of our operating expenses for the next 24
months.
|
|
•
|
an
invitation or inducement to engage in investment activity (within
the
meaning of Section 21 of the Financial Services and Markets Act
2000 (the
“FSMA”)) has only been communicated or caused to be
communicated and will only be communicated or caused to be communicated
)
in connection with the issue or sale of the securities in circumstances
in
which Section 21(1) of the FSMA does not apply to us;
and
|
|
•
|
all
applicable provisions of the FSMA have been complied with and
will be
complied with, with respect to anything done in relation to the
securities in, from or otherwise involving the United
Kingdom.
|
|
|
Page
|
Report
of Independent Registered Public Accounting Firm
|
|
F-2
|
|
|
|
Financial
Statements
|
|
|
|
|
|
Balance
Sheet as of July 13, 2007
|
|
F-3
|
|
|
|
Statement
of Operations for the period from July 10, 2007 (inception) to
July 13,
2007
|
|
F-4
|
|
|
|
Statement
of Stockholders’ Equity for the period from July 10, 2007 (inception) to
July 13, 2007
|
|
F-5
|
|
|
|
Statement
of Cash Flows for the period from July 10, 2007 (inception) to
July 13,
2007
|
|
F-6
|
|
|
|
Notes
to Financial Statements for the period from July 10, 2007 (inception)
to
July 13, 2007
|
|
F-7
|
Assets
|
|
|
|
|
Current
asset - Cash
|
|
$
|
225,000
|
|
Deferred
offering costs
|
19,037
|
|||
Total
assets
|
|
$
|
244,037
|
|
|
||||
Liabilities
and Stockholder’s Equity
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
Accrued
expenses
|
|
$
|
731
|
|
Accrued
offering costs
|
19,037
|
|||
Note
payable to affiliate
|
|
|
200,000
|
|
Total
current liabilities
|
|
|
219,768
|
|
|
||||
Commitments
|
|
|
|
|
Stockholder’s
equity:
|
|
|
|
|
Preferred
stock, $0.0001 par value, 5,000 shares
|
|
|
|
|
authorized;
none issued and outstanding
|
|
—
|
|
|
Common
Stock, $0.0001 par value, 106,000,000 shares
|
|
|
|
|
authorized;
8,625,000 shares issued and outstanding
|
|
|
862
|
|
Additional
paid-in capital
|
|
|
24,138
|
|
Deficit
accumulated during the development stage
|
|
|
(731
|
)
|
Total
stockholder’s equity
|
|
|
24,269
|
|
Total
liabilities and stockholder’s equity
|
|
$
|
244,037
|
|
|
|
|
||
Formation
costs
|
|
$
|
731
|
|
Net
loss
|
|
$
|
(731
|
)
|
Basic
and diluted net loss per share
|
|
$
|
(0.00
|
)
|
Weighted
average shares outstanding – basic and diluted
|
|
|
8,625,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deficit
Accumulated
|
|
|
|
|
|
|
|
|
Common
Stock
|
|
|
Additional
Paid-In
|
|
|
During
the Development
|
|
|
Stockholder’s
|
|
|||||||
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Stage
|
|
Equity
|
|
|||||
Sale
of shares at approximately $0.003 per share on July 13,
2007
|
|
8,625,000
|
|
|
$
|
862
|
|
|
$
|
24,138
|
|
|
|
|
|
|
$
|
25,000
|
|
Net
loss
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
(731
|
)
|
|
|
(731
|
)
|
Balances
at July 13, 2007
|
|
8,625,000
|
|
|
$
|
862
|
|
|
$
|
24,138
|
|
|
$
|
(731
|
)
|
|
$
|
24,269
|
|
|
Cash
flows from operating activities:
|
|
|
|
|
Net
loss
|
|
$
|
(731
|
)
|
Adjustments
to reconcile net loss
to net cash used in operating activities
|
||||
Increase
in accrued
expenses
|
731
|
|||
Net
cash used in operating
activities
|
|
|
-
|
|
Cash
flows from financing activities:
|
|
|
|
|
Proceeds
from note payable to
affiliate
|
|
|
200,000
|
|
Proceeds
from sale of
stock
|
|
|
25,000
|
|
Net
cash provided by financing
activities
|
|
|
225,000
|
|
Net
increase in cash
|
|
|
225,000
|
|
Cash
at beginning of period
|
|
|
—
|
|
Cash
at end of period
|
|
$
|
225,000
|
|
Supplemental
schedule of non-cash financing activities
Accrual
of deferred offering costs
|
$
|
19,037
|
Initial
Trustee’s fee
|
$ | 1,000 | (1) | |
SEC
Registration Fee
|
18,536
|
|||
FINRA
filing fee
|
60,875
|
|||
American
Stock Exchange filing and listing fee
|
70,000
|
|||
Accounting
fees and expenses
|
60,000
|
|||
Printing
and engraving expenses
|
90,000
|
|||
Directors
and Officers liability insurance premiums
|
300,000 | (2) | ||
Legal
fees and expenses
|
400,000
|
|||
Miscellaneous
|
100,000 | (3) | ||
Total
|
1,100,411
|
(1)
|
In
addition to the initial acceptance fee that is charged by Continental
Stock Transfer & Trust Company, as trustee, the registrant will be
required to pay to Continental Stock Transfer & Trust Company annual
fees of $_______ for acting as trustee, as transfer agent of
the
registrant’s common stock, as warrant agent for the registrant’s
warrants.
|
(2)
|
This
amount represents the approximate amount of director and officer
liability
insurance premiums the registrant anticipates paying over two
years
following the consummation of its initial public offering and
until it
consummates a business combination.
|
(3)
|
This
amount represents additional expenses that may be incurred by
the
registrant in connection with the offering over and above those
specifically listed above, including distribution and mailing
costs.
|
Stockholders
|
Number
of Shares
|
|||
NRDC
Capital Management, LLC
|
8,625,000
|
|||
Exhibit
No.
|
Description
|
|
1.1
|
Form
of Underwriting Agreement
|
|
3.1
|
Second
Amended & Restated Certificate of Incorporation*
|
|
3.2
|
By-Laws*
|
|
4.1
|
Specimen
Unit Certificate
|
|
4.2
|
Specimen
Common Stock Certificate*
|
|
4.3
|
Specimen
Warrant Certificate
|
|
4.4
|
Form
of Warrant Agreement between Continental Stock Transfer & Trust
Company and the Registrant
|
|
5.1
|
Opinion
of Sidley Austin LLP
|
|
10.1
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and NRDC
Capital Management, LLC
|
|
10.2
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and William
L. Mack
|
|
10.3
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Robert
C. Baker
|
|
10.4
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Richard
A. Baker
|
|
10.5
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Lee S.
Neibart
|
|
10.6
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Michael
J. Indiveri
|
|
10.7
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Edward
H. Meyer
|
|
10.8
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Laura
Pomerantz
|
|
10.9
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Vincent
Tese
|
|
10.10
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Ronald
W. Tysoe
|
|
10.11
|
Form
of Investment Management Trust Agreement between Continental
Stock
Transfer & Trust Company and the Registrant
|
|
10.12
|
Form
of Letter Agreement between NRDC Capital Management, LLC and
the
Registrant regarding office space and administrative
services*
|
|
10.13
|
Promissory
Note issued by the Registrant to NRDC Capital Management,
LLC*
|
|
10.14
|
Form
of Registration Rights Agreement between the Registrant and
NRDC Capital
Management, LLC
|
|
10.15
|
Subscription
Agreement between the Registrant and NRDC Capital Management,
LLC*
|
|
10.16
|
Private
Placement Warrant Purchase Agreement between the Registrant
and NRDC
Capital Management, LLC
|
|
10.17
|
Form
of Right of First Offer Agreement among the Registrant and
NRDC Capital
Management, LLC, NRDC Real Estate Advisors, LLC, NRDC Equity
Partners,
William L. Mack, Robert C. Baker, Richard A. Baker, Lee S.
Neibart,
Michael J. Indiveri, Edward H. Meyer, Laura Pomerantz, Vincent
Tese and
Ronald W. Tysoe
|
|
10.18
|
Co-investment
Agreement between the Registrant and NRDC Capital Management,
LLC
|
Exhibit
No.
|
Description
|
10.19
|
Letter
Agreement between the Registrant and Apollo Real Estate
Advisors
|
|
14
|
Code
of Ethics*
|
|
23.1
|
Consent
of Goldstein Golub Kessler LLP
|
|
23.2
|
Consent
of Sidley Austin LLP
(included in Exhibit 5.1)
|
|
24
|
Power
of Attorney (included on the signature page of this registration
statement)
|
|
99.1
|
Audit
Committee Charter*
|
|
99.2
|
Nominating
Committee Charter*
|
|
*
Previously filed
|
||
NRDC ACQUISITION CORP. | |||
|
By:
|
/s/ Richard
A.
Baker
|
|
Richard
A.
Baker
|
|||
Chief
Executive Officer
|
|||
(Principal
Executive Officer)
|
|||
Name
|
Position
|
Date
|
||
*
William
L. Mack
|
Chairman
of the Board
|
September
27, 2007
|
||
*
Robert
C. Baker
|
Vice
Chairman of the Board
|
September
27, 2007
|
||
/s/ Richard
A. Baker
Richard
A. Baker
|
Chief
Executive Officer and Director (principal executive officer,
principal
accounting officer and principal financial officer)
|
September
27, 2007
|
||
*
Lee
S. Neibart
|
President
and Director
|
September
27, 2007
|
*
Michael
J. Indiveri
|
Director
|
September
27, 2007
|
||
*
Edward
H. Meyer
|
Director
|
September
27, 2007
|
||
*
Laura
Pomerantz
|
Director
|
September
27, 2007
|
||
/s/ Vincent
Tese
Vincent
Tese
|
Director
|
September
27, 2007
|
||
*
Ronald
W. Tysoe
|
Director
|
September
27, 2007
|
*By:
|
/s/ Richard
A.
Baker
|
|
|
||
Richard
A. Baker
|
|||||
Attorney-in-Fact
|
|||||
Exhibit
No.
|
Description
|
1.1
|
Form
of Underwriting Agreement
|
3.1
|
Second
Amended & Restated Certificate of Incorporation*
|
3.2
|
By-Laws*
|
4.1
|
Specimen
Unit Certificate
|
4.2
|
Specimen
Common Stock Certificate*
|
4.3
|
Specimen
Warrant Certificate
|
4.4
|
Form
of Warrant Agreement between Continental Stock Transfer & Trust
Company and the Registrant
|
5.1
|
Opinion
of Sidley Austin LLP
|
10.1
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and NRDC
Capital Management, LLC
|
10.2
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and William
L. Mack
|
10.3
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Robert
C. Baker
|
10.4
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Richard
A. Baker
|
10.5
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Lee S.
Neibart
|
10.6
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Michael
J. Indiveri
|
10.7
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Edward
H. Meyer
|
10.8
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Laura
Pomerantz
|
10.9
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Vincent
Tese
|
10.10
|
Letter
Agreement among the Registrant, Banc of America Securities
LLC and Ronald
W. Tysoe
|
10.11
|
Form
of Investment Management Trust Agreement between Continental
Stock
Transfer & Trust Company and the Registrant
|
10.12
|
Form
of Letter Agreement between NRDC Capital Management, LLC and
the
Registrant regarding office space and administrative
services*
|
10.13
|
Promissory
Note issued by the Registrant to NRDC Capital Management,
LLC*
|
10.14
|
Form
of Registration Rights Agreement between the Registrant and
NRDC Capital
Management, LLC
|
10.15
|
Subscription
Agreement between the Registrant and NRDC Capital Management,
LLC*
|
10.16
|
Private
Placement Warrant Purchase Agreement between the Registrant
and NRDC
Capital Management, LLC
|
10.17
|
Form
of Right of First Offer Agreement among the Registrant and
NRDC Capital
Management, LLC, NRDC Real Estate Advisors, LLC, NRDC Equity
Partners,
William L. Mack, Robert C. Baker, Richard A. Baker, Lee S.
Neibart,
Michael J. Indiveri, Edward H. Meyer, Laura Pomerantz, Vincent
Tese and
Ronald W. Tysoe
|
10.18
|
Co-investment
Agreement between the Registrant and NRDC Capital Management,
LLC*
|
10.19
|
Letter
Agreement between the Registrant and Apollo Real Estate
Advisors
|
14
|
Code
of Ethics*
|
23.1
|
Consent
of Goldstein Golub Kessler LLP
|
23.2
|
Consent
of Sidley Austin LLP
(included in Exhibit 5.1)
|
Exhibit
No.
|
Description
|
24
|
Power
of Attorney (included on the signature page of this registration
statement)
|
99.1
|
Audit
Committee Charter*
|
99.2
|
Nominating
Committee Charter*
|
*Previously
filed
|